Agilent Technologies, Inc. (A) is listed on NYSE in the Healthcare sector Β· Diagnostics & Research industry. The current price is 153.43, down -3.50% from the previous close. Market cap is approximately $44.9B.
The commentary below is auto-generated by comparing market data (P/E, ROE, D/E, etc.) against predefined thresholds. No LLM is used. This is not a buy/sell recommendation from us or any analyst. For reference only.
Agilent Technologies, Inc. trades at a premium P/E of 31.93x, with a lot of growth priced in. A single quarter that misses consensus can compress the multiple sharply.
Agilent Technologies, Inc.'s 21.33% ROE places it in the elite band. Companies that sustain ROE above 15% for years usually have a structural moat (brand, network effects, cost advantage).
A's D/E at 49.73 is on the high side. Credit rating, debt maturity ladder, and refinancing risk all become first-order considerations.
Revenue is growing 10.00% year-over-year. Double-digit growth often reflects share gains or new-market entry.
A's 0.64% dividend yield is low. Check the dividend growth trend and payout ratio for room to expand.
Pharma and biotech are typically valued through risk-adjusted NPV/DCF on the pipeline.
Agilent Technologies, Inc. is near its 52-week high (160.51), in the top 14% of the range. Prices close to new highs invite two readings β little overhead supply, or stretched expectations β and volume is the usual tiebreaker.
Your watchlist and portfolio, one tap from your home screen β the Margin Call app
The day's high-to-low spread reached 3.60%, with a -3.50% move. Wide sessions frequently follow earnings, filings, or sector news, so identifying the catalyst matters.
Agilent Technologies, Inc. (A) is listed on NYSE, with recent volume of 3,945,982 shares. Volume is a supporting gauge of how much conviction sits behind a price move β the same gain reads differently on heavy versus light turnover.